GLYCATED ALBUMIN: THE MISSING PIECE IN DIABETES TESTING
GSP serves as an accurate intermediate marker of glycemia in instances where HbA1c may be of limited value such as pregnancy, reduced RBC lifespan and hemodialysis. The difference between actual measured HbA1c and predicted HbA1c from glycated serum protein is called the glycation gap.
Measuring HbA1c and GSP together offers improved diagnostic accuracy by more reliably predicting complications of diabetes including nephropathy and retinopathy. GSP provides superior specificity and accuracy compared to fructosamine assays (NBT method) for monitoring and assessment of short-term to medium-term (past two to three week period) average blood glucose levels. Complementary to HbA1c in diagnosis and screening of diabetes. Studies suggest that combining GSP results with HbA1c measurements provides a better assessment of long term risk of diabetic complications. The reagent, controls and calibrators are all liquid stable and offer the added convenience of instrument specific packaging
GESAN GLYCATED SERUM PROTEIN ASSAY ADVANTAGES
• Gesan’s method eliminates the inaccuracies caused by non-glycated protein reducing substances which interfere with the NBT fructosamine method
• Gesan’s GSP test utilizes the specificity of fructosylamino oxidase to eliminate significant interferences
• Gesan’s enzymatic method is more reliable and specific than the older non-enzymatic fructosamine NBT method
• User friendly instrument specific (Chem 200 & Chem 300 plus & Chem 400) packaging options available
• Part of Gesan special diabetes markers
• A wide range of instrument parameters are offered for facilitating and simplifying implementation
Download Gesan Highlights flyer for assay specification, precision and interferences data
